Medicines advice

Search Filters

Know what you're looking for?

Submission type

British National Formulary - Chapter

Pharmaceutical company

From

To

Advice

Accepted Not recommended Restricted Superseded Withdrawn Interim acceptance

Process

End of life/orphan Ultra orphan

Additional Details

Patient Access Scheme

Advanced Search

SMC ID	Date	Medicine	Submission Type	Indication
1191/16	12/09/2016	cobimetinib (Cotellic)	Non submission	In combination with vemurafenib for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation.
792/12	09/12/2013	vemurafenib (Zelboraf)	Resubmission	As monotherapy for the treatment of adult patients with BRAF V600 mutation-positive unresectable or metastatic melanoma.

No medicines have been found.